PUBLISHED ASSESSMENT

Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study - PubMed

This compact public record contains an assessment and source links. It does not contain article text, reader identity, browsing history, or private notes.

Historical provenance limit: this assessment has a recorded retrieval URL from before Beaconwright’s current publisher-verification boundary. It has not been reverified under the current boundary.

Open original article

The abstract presents a large self-controlled study with clear numerical reporting and useful absolute-risk context. Independent evidence broadly supports a much greater GBS association with influenza illness than vaccination, while findings on a small seasonal-vaccine association remain mixed. Administrative-code ascertainment and limited methodological detail constrain evaluation of misclassification, confounding, and robustness.

Evidence support

Substantial (73/100)

The reported small post-vaccination association is consistent with several population studies and one meta-analysis.
Independent literature broadly supports a substantially greater GBS association with influenza-like illness than with vaccination.
A later meta-analysis and surveillance studies did not find a statistically significant seasonal-vaccine association, limiting certainty.
Vaccination, influenza exposure, and GBS were identified through administrative codes rather than confirmed vaccination records, laboratory diagnoses, and chart-adjudicated cases.

Balance & context

Substantial (68/100)

The abstract reports relative risks, confidence intervals, and attributable risks, placing the rare vaccine-associated outcome in absolute context.
It compares vaccination with influenza-related encounters rather than discussing vaccine risk in isolation.
The interpretation appropriately recommends communicating both risks.
The abstract does not adequately discuss exposure misclassification, residual seasonal confounding, diagnostic validation, or the distinction between coded encounters and confirmed influenza infection.

Transparency

Substantial (76/100)

Authors, affiliations, publication date, DOI, funding source, study period, design, statistical model, intervals, case counts, and confidence intervals are disclosed.
Exposure and outcome definitions are briefly described.
The provided record does not show conflict-of-interest disclosures, validation results, sensitivity analyses, analytical code, protocol, or accessible underlying data.

Confidence and coverage

Confidence in this analysis: Moderate confidence

Evidence coverage: Partial coverage

Assessment is based primarily on the abstract rather than the complete article, supplementary methods, or underlying data.
Administrative codes were not independently checked against clinical records here.
Later studies and meta-analyses reach differing conclusions about whether seasonal vaccination measurably increases GBS risk.

Multiple independent studies and reviews permit comparison of the central conclusions.
Only the abstract of the assessed study was available, preventing detailed evaluation of methods and robustness checks.
The literature is consistent about influenza illness presenting greater risk but mixed about the statistical detectability of seasonal-vaccine risk.

Sources considered

Guillain-Barré syndrome, influenza, and influenza vaccination: the epidemiologic evidence — Review reports that infection-associated risk is several times greater than the small risk found in some vaccine studies.
Guillain-Barré syndrome and influenza vaccines: A meta-analysis — Found a small, marginally significant association for seasonal influenza vaccines.
Is an Increased Risk of Developing Guillain-Barré Syndrome Associated with Seasonal Influenza Vaccination? A Systematic Review and Meta-Analysis — Found no statistically significant pooled seasonal-vaccine association but a strong association with influenza-like illness.
Seasonal influenza vaccine and Guillain-Barré syndrome — A later French analysis found no increased GBS incidence during the 42-day post-vaccination period.
Guillain-Barré syndrome after influenza vaccination in adults: a population-based study — Earlier Ontario research found a similarly small increased relative incidence after vaccination.

This assesses evidence and presentation; it is not an overall truth verdict.

Reassess

⚠ Paid reassessment incurs a charge. Opening this page does not start a run or incur a charge.

To request a new assessment, sign in to My library, watch this record, and select Request new assessment. Requests await separate approval and do not themselves start a paid run.

A new assessment may differ. Earlier published results remain in history.

Open My library

Assessment history

Published assessment trend

Available public snapshots only; this is not a count of all executions. Corrections may include earlier scores. Gaps mean not scored or not recorded. Different scores do not establish changed source evidence.

Evidence support — solid blueBalance & context — dashed purpleTransparency — dotted green

Reassess ⚠

Recorded public scores (0–100)
Date	Evidence support	Balance & context	Transparency
2026-09-12 (current)	73	68	76